
Changhwa J. Cheu
Examiner (ID: 19221, Phone: (571)272-0814 , Office: P/1678 )
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1641, 1678, 1677 |
| Total Applications | 1736 |
| Issued Applications | 1112 |
| Pending Applications | 174 |
| Abandoned Applications | 494 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17387045
[patent_doc_number] => 20220034897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => ASSAYS FOR DETECTING MODIFIED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/501143
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501143
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501143 | Assays for detecting modified compounds | Oct 13, 2021 | Issued |
Array
(
[id] => 17371361
[patent_doc_number] => 20220026413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Biosensor for Male Infertility
[patent_app_type] => utility
[patent_app_number] => 17/492331
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492331 | Biosensor for male infertility | Sep 30, 2021 | Issued |
| 17/492372 | METHOD FOR DETERMINING A CONCENTRATION OF N-TERMINAL PRO-HORMONE BNP (NT-PROBNP) IN A SAMPLE | Sep 30, 2021 | |
Array
(
[id] => 17344991
[patent_doc_number] => 20220011322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHOD AND KIT FOR THE DETECTION OF PANCREATIC DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/487089
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17487089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/487089 | Method and kit for the detection of pancreatic dysfunction | Sep 27, 2021 | Issued |
Array
(
[id] => 18719203
[patent_doc_number] => 11796541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Methods for assessing mucosal healing in ulcerative colitis disease patients
[patent_app_type] => utility
[patent_app_number] => 17/483462
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 14648
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483462 | Methods for assessing mucosal healing in ulcerative colitis disease patients | Sep 22, 2021 | Issued |
Array
(
[id] => 18740911
[patent_doc_number] => 20230349889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => Methods of Determining Immune Response
[patent_app_type] => utility
[patent_app_number] => 18/025763
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025763
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025763 | Methods of Determining Immune Response | Sep 9, 2021 | Pending |
Array
(
[id] => 18755323
[patent_doc_number] => 20230358752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => Assay for Assessing Cancer
[patent_app_type] => utility
[patent_app_number] => 18/025704
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025704
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025704 | Assay for Assessing Cancer | Sep 9, 2021 | Abandoned |
Array
(
[id] => 19668746
[patent_doc_number] => 12181485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Methods of blood screening
[patent_app_type] => utility
[patent_app_number] => 17/471620
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 21
[patent_no_of_words] => 42986
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 321
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471620 | Methods of blood screening | Sep 9, 2021 | Issued |
Array
(
[id] => 17371370
[patent_doc_number] => 20220026422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => GLOBAL PROTEOMIC SCREENING OF RANDOM BEAD ARRAYS USING MASS SPECTROMETRY IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/464850
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464850
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/464850 | Global proteomic screening of random bead arrays using mass spectrometry imaging | Sep 1, 2021 | Issued |
Array
(
[id] => 19143580
[patent_doc_number] => 20240142453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => AKR1C3 DETECTION METHOD, AND DIAGNOSTIC KIT FOR DETECTING AKR1C3 AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/043610
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043610
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043610 | AKR1C3 DETECTION METHOD, AND DIAGNOSTIC KIT FOR DETECTING AKR1C3 AND USE THEREOF | Aug 25, 2021 | Pending |
Array
(
[id] => 19077578
[patent_doc_number] => 11946935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Circulating tumor markers for meningiomas
[patent_app_type] => utility
[patent_app_number] => 17/411524
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 24
[patent_no_of_words] => 12636
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17411524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/411524 | Circulating tumor markers for meningiomas | Aug 24, 2021 | Issued |
Array
(
[id] => 18650787
[patent_doc_number] => 20230296622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => COMPOSITIONS AND METHODS OF PREDICTING TIME TO ONSET OF LABOR
[patent_app_type] => utility
[patent_app_number] => 18/019228
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019228
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019228 | COMPOSITIONS AND METHODS OF PREDICTING TIME TO ONSET OF LABOR | Aug 16, 2021 | Pending |
Array
(
[id] => 18863305
[patent_doc_number] => 20230417741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => NANOPARTICLE-ENABLED ANALYSIS OF CELL-FREE NUCLEIC ACID IN COMPLEX BIOLOGICAL FLUIDS
[patent_app_type] => utility
[patent_app_number] => 18/041141
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041141
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041141 | NANOPARTICLE-ENABLED ANALYSIS OF CELL-FREE NUCLEIC ACID IN COMPLEX BIOLOGICAL FLUIDS | Aug 8, 2021 | Pending |
Array
(
[id] => 20137268
[patent_doc_number] => 20250244312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-31
[patent_title] => EX VIVO COLONIC BIOPSY PLATFORM TO EVALUATE MULTI-OMIC SIGNATURES FOR SCREENING CANDIDATE THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 18/040422
[patent_app_country] => US
[patent_app_date] => 2021-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040422
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040422 | EX VIVO COLONIC BIOPSY PLATFORM TO EVALUATE MULTI-OMIC SIGNATURES FOR SCREENING CANDIDATE THERAPEUTICS | Aug 4, 2021 | Pending |
Array
(
[id] => 19374881
[patent_doc_number] => 12066442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Method of assessing risk of PML
[patent_app_type] => utility
[patent_app_number] => 17/393335
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 23
[patent_no_of_words] => 27229
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 320
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17393335
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/393335 | Method of assessing risk of PML | Aug 2, 2021 | Issued |
Array
(
[id] => 18787285
[patent_doc_number] => 20230375553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => A RATIO BETWEEN PLGF AND SFLT1 IS PREDICTIVE FOR NEURAL INVASION IN PATIENTS SUFFERING FROM PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 18/000989
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000989
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000989 | A RATIO BETWEEN PLGF AND SFLT1 IS PREDICTIVE FOR NEURAL INVASION IN PATIENTS SUFFERING FROM PANCREATIC CANCER | Jul 7, 2021 | Pending |
Array
(
[id] => 17300921
[patent_doc_number] => 20210396760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => Super-Resolution Immunofluorescence with Diffraction-Limited Preview
[patent_app_type] => utility
[patent_app_number] => 17/363416
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/363416 | Super-Resolution Immunofluorescence with Diffraction-Limited Preview | Jun 29, 2021 | Pending |
Array
(
[id] => 18498590
[patent_doc_number] => 20230221298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => SUPERABSORBENT POLYMER FOR CLASSIFICATION OF PARTICLES AND CLASSIFICATION METHOD USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/009429
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7710
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009429
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009429 | SUPERABSORBENT POLYMER FOR CLASSIFICATION OF PARTICLES AND CLASSIFICATION METHOD USING THE SAME | Jun 9, 2021 | Pending |
Array
(
[id] => 17113231
[patent_doc_number] => 20210293828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => COLLAGEN TYPE VII ALPHA 1 ASSAY
[patent_app_type] => utility
[patent_app_number] => 17/339317
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339317
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/339317 | COLLAGEN TYPE VII ALPHA 1 ASSAY | Jun 3, 2021 | Abandoned |
Array
(
[id] => 18336826
[patent_doc_number] => 20230128775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => BIOMARKER IDENTIFICATION FOR IMMINENT AND/OR IMPENDING HEART FAILURE
[patent_app_type] => utility
[patent_app_number] => 17/545112
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17545112
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/545112 | Biomarker identification for imminent and/or impending heart failure | Jun 2, 2021 | Issued |